Boc-D-Glu-OEt · DCHA

Boc-D-Glu-OEt · DCHA is a protected D-glutamate derivative featuring a Boc-protected amino group and an ethyl ester at the side-chain carboxyl position, provided as a dicyclohexylamine (DCHA) salt to improve handling and solid-state properties for synthesis workflows. This form is routinely selected as a glutamate building block when stereodefined incorporation of the D-configuration and ester/acid-derivation control are required for subsequent peptide assembly or intermediate elaboration. The protected functionality also supports downstream transformations that depend on orthogonal reactivity between the protected amine and the esterified carboxyl group.

1. Peptide Synthesis Building Block

Boc-D-Glu-OEt · DCHA is used by peptide chemists as a stereodefined D-glutamate building block for constructing peptides and peptidomimetics where glutamate side-chain geometry and controlled carboxyl functionality are essential. The Boc-protected amino group aligns with Boc-based peptide synthesis strategies and supports segment condensation workflows, while the ethyl ester enables selective downstream conversion to the corresponding free acid or activated carboxylate at a chosen stage. Researchers in custom peptide manufacturing and academic peptide synthesis groups commonly select this derivative when they need to introduce D-glutamate residues to probe structure-property relationships, tune conformational preferences, or generate peptides designed to resist enzymatic processing in chemical biology studies.

2. Pharmaceutical Intermediate Development

Boc-D-Glu-OEt · DCHA is also applied as a practical intermediate for building glutamate-derived fragments used in medicinal chemistry and specialty chemical development. The combination of a protected amine (Boc) with an esterified carboxyl group provides a stable, isolable platform for iterative functional group manipulations, enabling preparation of downstream activated acids, amides, or coupling-ready carboxylates from the glutamate scaffold. Process development teams and intermediate suppliers often prefer salt-form protected derivatives like the DCHA salt for improved weighability and reproducibility in multistep synthesis, particularly when scaling peptide-adjacent or amino acid-derived intermediates for library or candidate synthesis.

3. Stereodefined Amino Acid Derivatization

Boc-D-Glu-OEt · DCHA serves as a stereochemical control reagent for preparing D-glutamate-containing analogs and side-chain-modified derivatives used in analytical method development and chemical biology tool synthesis. By maintaining the D-configuration while keeping key functional groups protected, the reagent supports consistent derivatization routes that require later unmasking or transformation of the carboxyl functionality without premature side reactions. This is particularly relevant for researchers generating reference materials, standards, or specialized glutamate analogs where stereochemical integrity and functional group timing are critical to downstream coupling, labeling, or derivatization steps.

4. Solid-Phase Compatible Segment Assembly

Boc-D-Glu-OEt · DCHA is frequently incorporated into protected segment strategies where the glutamate residue must be introduced with defined stereochemistry and protected functional groups prior to assembly into larger peptide constructs. In workflows that rely on preassembled protected amino acid segments, the Boc-protected amine supports controlled deprotection and coupling sequencing, while the ester group provides a handle for later conversion to the corresponding acid form as the synthesis progresses. Peptide synthesis groups developing complex sequences, including D-amino acid-containing peptides and glutamate-rich motifs, use this derivative to manage reactivity across multiple functional groups during iterative assembly.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII